C4 Therapeutics logo
Healthcare & Life Sciences

C4 Therapeutics

C4 Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 5 tracked investors.

Activeseries-c-plus
series-c-plus
Stage
2015
Founded
5
Investors

About C4 Therapeutics

C4 Therapeutics is a startup founded in 2015 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.

C4 Therapeutics develops targeted protein degraders, a novel class of medicines that harness targeted protein degradation to treat diseases such as multiple myeloma, with clinical candidates like cemsidomide in Phase 1 trials.

Explore C4 Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States